High deprivation areas given funding to boost structured medication reviews, says HIN The Health Innovation Network said that 25 primary care networks would be funded to provide supportive materials that had been shown to improve SMR outcomes.…
NICE rejects second Alzheimer’s disease treatment for NHS use Clinical trial evidence reveals that there are “significant health risks” linked to donanemab, with a third of patients experiencing amyloid-related imaging abnormalities as a result of brain swelling and bleeding.…
RPS to survey members before responding to government consultation on NHS ten-year plan The Royal Pharmaceutical Society said it wants the government to place supporting patient access to community pharmacies at the heart of any increase in neighbourhood health services.…
Manufacturer withdraws treatment for sickle cell disease following concern over deaths Pfizer's withdrawal is based on data that suggest “an imbalance in vast-occlusive crises and fatal events which require further assessment”.…
Regulator misses fitness-to-practise timeliness standard for sixth year in a row The Professional Standards Authority said the General Pharmaceutical Council “is still taking too long to progress fitness-to-practise investigations”.…
Is the General Pharmaceutical Council making progress to improve its fitness-to-practise processes? A closer look at measures being put in place to alleviate the rapid growth of fitness-to-practise concerns, an issue the pharmacy regulator has dubbed an “unprecedented challenge”.…
Mark Drakeford appointed as Welsh health and social care cabinet secretary The former first minister of Wales has been appointed to the cabinet on an interim basis.…
GPhC reveals lowest summer registration assessment pass rate for five years The exam results showed a pass rate of 75%, down from the 77% pass rate for the 2023 summer assessment.…
EMA tells countries to prioritise weight loss drugs for patients ‘with greatest need’ A European Medicines Agency steering group has asked member countries to work with marketing authorisation holders to “control and optimise the distribution” of glucagon-like peptide-1 receptor agonists.…
Bristol pharmacist given RPS Charter Award Ade Williams received the Charter Award from the Royal Pharmaceutical Society for demonstrating pharmacy’s role in providing comprehensive and affordable healthcare solutions for the community.…